- Home
- RQI vs BHVN Comparison
RQI vs BHVN Comparison
Compare RQI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RQI
- BHVN
- Stock Information
- Founded
- RQI 2002
- BHVN 2013
- Country
- RQI United States
- BHVN United States
- Employees
- RQI N/A
- BHVN N/A
- Industry
- RQI Trusts Except Educational Religious and Charitable
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- RQI Finance
- BHVN Health Care
- Exchange
- RQI Nasdaq
- BHVN Nasdaq
- Market Cap
- RQI 1.7B
- BHVN 1.9B
- IPO Year
- RQI N/A
- BHVN 2017
- Fundamental
- Price
- RQI $12.46
- BHVN $15.13
- Analyst Decision
- RQI
- BHVN Strong Buy
- Analyst Count
- RQI 0
- BHVN 14
- Target Price
- RQI N/A
- BHVN $59.85
- AVG Volume (30 Days)
- RQI 432.6K
- BHVN 2.4M
- Earning Date
- RQI 01-01-0001
- BHVN 05-12-2025
- Dividend Yield
- RQI 8.20%
- BHVN N/A
- EPS Growth
- RQI N/A
- BHVN N/A
- EPS
- RQI N/A
- BHVN N/A
- Revenue
- RQI N/A
- BHVN N/A
- Revenue This Year
- RQI N/A
- BHVN N/A
- Revenue Next Year
- RQI N/A
- BHVN $65.26
- P/E Ratio
- RQI N/A
- BHVN N/A
- Revenue Growth
- RQI N/A
- BHVN N/A
- 52 Week Low
- RQI $9.17
- BHVN $14.33
- 52 Week High
- RQI $12.64
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- RQI 56.08
- BHVN 31.09
- Support Level
- RQI $11.94
- BHVN $14.86
- Resistance Level
- RQI $12.29
- BHVN $15.94
- Average True Range (ATR)
- RQI 0.20
- BHVN 1.27
- MACD
- RQI 0.00
- BHVN -0.16
- Stochastic Oscillator
- RQI 82.54
- BHVN 3.31
About RQI Cohen & Steers Quality Income Realty Fund Inc
COHEN & STEERS QUALITY INCOME REALTY FUND INC is a diversified, closed-end management investment company. The primary investment objective of the Fund is high current income through investment in real estate securities. Its secondary objective is capital appreciation. The Fund invests at least its total assets in income-producing common stocks and other securities issued by real estate companies, such as real estate investment trusts under normal market conditions.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.